Redefine What’s Possible: a Potential New Treatment Paradigm for Patients with Preeclampsia and Stroke
DiaMedica Therapeutics is committed to improving the lives of individuals battling serious vascular diseases by developing innovative therapies that reduce ischemia. With an initial focus on preeclampsia (PE) and acute ischemic stroke (AIS), we are dedicated to advancing patient care through a novel approach that centers around improving blood flow to ischemic tissue (collateral circulation) to improve patient outcomes.
More About DiaMedica